Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Fujiwara, K; Harter, P; Leary, A; Perol, D; Pignata, S; Gonzalez-Martin, A; Petru, E; van Nieuwenhuysen, E; Colombo, N; Maenpaa, J; Selle, F; de Gregorio, N; Lorusso, D; Alia, EMG; Lefeuvre-Plesse, C; Buderath, P; Lortholary, A; Burges, A; Pujade-Lauraine, E; Ray-Coquard, IL.
Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) Asia Congress; NOV 22-24, 2019; Singapore, SINGAPORE. [Keynote lecture]
Web of Science

Authors Med Uni Graz:: Petru Edgar
Altmetrics: